Abbott, WARF Clash With Teva Over Zemplar
Abbott Laboratories and the Wisconsin Alumni Research Foundation have initiated a patent lawsuit aimed at keeping Teva Pharmaceutical Industries Ltd. from marketing a generic version of the drug Zemplar, used to...To view the full article, register now.
Already a subscriber? Click here to view full article